Search research articles
Contact Us
Filters
Showing results (751-760 of 1,115) with videos related to
Page
of 112
Sort By:
Nucleic Acids Research
|
May 26, 2009
HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy
Heike Summer, Ou Li, Qiuye Bao, et al.
The Journal of Surgical Research
|
January 30, 2019
Lower Extremity Duplex Ultrasound Screening Protocol for Moderate- and High-Risk Trauma Patients
Grace E Martin, Amanda Pugh, Susan G Williams, et al.
The Journal of Trauma and Acute Care Surgery
|
March 23, 2022
Effects of antifibrinolytics on systemic and cerebral inflammation after traumatic brain injury
Taylor E Wallen, Kathleen E Singer, Matthew R Baucom, et al.
The Journal of Surgical Research
|
November 13, 2025
Early Hypercalcemia Is Associated With Mortality in Critically Ill, Transfused Trauma Patients
Ellen R Becker, Catherine G Pratt, Jenna N Whitrock, et al.
The Journal of Surgical Research
|
October 18, 2024
Porcine Packed Red Blood Cells Demonstrate a Distinct Red Blood Cell Storage Lesion
Ryan C Chae, Adam D Price, Matthew R Baucom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis
T L Vollmer, J T Phillips, A D Goodman, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2010
Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial
N D Freedman, T M Curto, C Morishima, et al.
The Journal of Surgical Research
|
September 24, 2022
Evaluating the Utility of High Sensitivity Troponin in Blunt Cardiac Injury
Jay N Nathwani, Matthew R Baucom, Ann Salvator, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2015
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials
Andrew D Goodman, Francois Bethoux, Theodore R Brown, et al.
Neurology
|
September 17, 1999
Quantitative assessment of motor fatigue and strength in MS
S R Schwid, C A Thornton, S Pandya, et al.
Page
of 112
Search research articles
Search
Showing results (751-760 of 1,115) with videos related to
Sort By:
Page
of 112
Nucleic Acids Research
|
May 26, 2009
HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy
Heike Summer, Ou Li, Qiuye Bao, et al.
The Journal of Surgical Research
|
January 30, 2019
Lower Extremity Duplex Ultrasound Screening Protocol for Moderate- and High-Risk Trauma Patients
Grace E Martin, Amanda Pugh, Susan G Williams, et al.
The Journal of Trauma and Acute Care Surgery
|
March 23, 2022
Effects of antifibrinolytics on systemic and cerebral inflammation after traumatic brain injury
Taylor E Wallen, Kathleen E Singer, Matthew R Baucom, et al.
The Journal of Surgical Research
|
November 13, 2025
Early Hypercalcemia Is Associated With Mortality in Critically Ill, Transfused Trauma Patients
Ellen R Becker, Catherine G Pratt, Jenna N Whitrock, et al.
The Journal of Surgical Research
|
October 18, 2024
Porcine Packed Red Blood Cells Demonstrate a Distinct Red Blood Cell Storage Lesion
Ryan C Chae, Adam D Price, Matthew R Baucom, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2004
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis
T L Vollmer, J T Phillips, A D Goodman, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2010
Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial
N D Freedman, T M Curto, C Morishima, et al.
The Journal of Surgical Research
|
September 24, 2022
Evaluating the Utility of High Sensitivity Troponin in Blunt Cardiac Injury
Jay N Nathwani, Matthew R Baucom, Ann Salvator, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2015
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials
Andrew D Goodman, Francois Bethoux, Theodore R Brown, et al.
Neurology
|
September 17, 1999
Quantitative assessment of motor fatigue and strength in MS
S R Schwid, C A Thornton, S Pandya, et al.
Page
of 112